PCRX FY 2023 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena

PCRXPacira BioSciences, Inc.

$971M

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$675M+1.2% YoY

Gross Profit

$490M72.6% margin

Operating Income

$88M13.0% margin

Net Income

$42M6.2% margin

EPS (Diluted)

$0.89

Cash Flow

Operating Cash Flow

$155M

Free Cash Flow

$139M

Stock-Based Comp.

$48M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$704M

Stockholders' Equity

$870M

Cash & Equivalents

$153M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$675M	$667M	+1.2%
Gross Profit	$490M	$468M	+4.9%
Operating Income	$88M	$60M	+46.1%
Net Income	$42M	$16M	+163.7%